Stockopedia | Share Prices, Share News and Company Research

Don't miss out on our next "How to Make the Most of Stockopedia" Webinar this Wednesday May 29th - sign up details here
MOMENTUM
Relative Strength (%)
1m
3m
1yr
Volume Change (%)
10d vs 3m
Price vs... (%)
52w High
50d MA
200d MA
vs.
market
vs.
industry
GROWTH & VALUE

IMPLIED MARGIN OF SAFETY (beta)
SCREENS PASSED 2
Balance Sheet · Income Statement · Cashflow FINANCIAL SUMMARY
Year End 31st Mar 2007 2008 2009 2010 2011 2012 TTM 2013E 2014E CAGR / Avg
Revenue £m
Operating Profit £m
Net Profit £m
EPS Reported p
EPS Normalised p
EPS Growth %
PE Ratio x
PEG x
Profitability
Operating Margin %
ROA %
ROCE %
ROE %
Cashflow
Op. Cashflow ps p
Capex ps p
Free Cashflow ps p
Dividends
Dividend ps p
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc £m
Working Capital £m
Net Fixed Assets £m
Net Debt £m
Book Value £m
Average Shares m
Book Value ps p -1.9%

FINANCIAL BRIEF: For the six months ended 30 September 2012, Spark Ventures Plc revenues decreased 9% to L1.3M. Net income increased from L237K to L1M. Revenues reflect Fund Management Revenue decrease of 32% to L380K, Bank Interest Receivable decrease of 61% to L33K. Net income reflects Unrealised gains and losses increase of 35% to L1.8M (income), Investment / Realised Gains increase from L187K (expense) to L37K (income). more »

HEALTH TREND

BANKRUPTCY RISK

  EARNINGS MANIPULATION RISK

MAGIC FORMULA SCORE

OTHER RATIOS
Leverage (ttm) Total Ex Intang
Gross Gearing %
Net Gearing %
Cash / Assets %

vs.
market
vs.
industry
RECENT HISTORY
Latest interim period (ended 30th Sep '12) vs. prior year
Sales Growth %
EPS Growth %
3yr Average Annualised
Sales Growth %
EPS Growth %
DPS Growth %

BROKER FORECASTS
31st Mar 2013
31st Mar 2014

Price Target: N/A Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a (£) (£) (£) (£) (£) (£)
Consensus Estimate
1m Change
3m Change
BROKER CONSENSUS & FORECAST TREND
Broker Recommendations for SPARK Ventures
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts:

Named Brokers and Analysts
There are no named brokers.

SPARK Venture Management is a United Kingdom-based venture capital firm. The Firm is focused on investing in early stage portfolio companies. The Firm invests in technology, media, and healthcare companies. Particular interests include network infrastructure, enterprise software, mobile commerce and applications, Internet, digital publishing, clean technology, medical devices, biological therapies, disease management, and specialty pharmaceuticals. Some of the Firms portfolio companies include: Aspex Semiconductor, Celldex Therapeutics, Inc., Celoxica Holdings, DEM Solutions, MediGene AG, Notonthehighstreet.com, Mind Candy, Kobalt Music, Oxford Immunotec, Perpetuum, Vivacta, and Xtera Communications, Inc.

Directors: Andrew Betton (Secy.) 41,

No. of Employees: 0 No. of Shareholders: n/a


Last Annual March 31st, 2012
Last Interim September 30th, 2012
Shares in Issue 410,755,000
Free Float 299.8m (73.0%)
Sector Financials
Industry Investment Banking & Investment Services
Index FTSE Aim All Share,
Exchange London Stock Exchange (AIM)
Eligible for an ISA? a SIPP?

SPK SHARE PRICE PERFORMANCE SPK QUOTE
SPK Share Price GBp
11.25p
Day's Change
0.0  0.0%
Traded 11:00am · Minimum 15 min delayed

LATEST SPK NEWS ANNOUNCEMENTS (delayed)

UPCOMING SPK EVENTS
No upcoming events.
Recent ↓
Monday 21st January, 2013
Dividend For SPK.L
Thursday 29th September, 2011
Dividend For SPK.L
Monday 25th October, 2010
SPARK VENTURES PLC at Opal Financial Group European Alternative & Institutional Investing Summit
Thursday 23rd September, 2010
Dividend For SPK.L
Thursday 23rd September, 2010
Dividend For SPKVF.PK
Thursday 23rd September, 2010
Dividend For NME.BE
Wednesday 5th August, 2009
Dividend For SPK.L


Should you buy SPK

Access SPK Analytics Now!

FREE TRIAL or TAKE THE TOUR